Scientists test new Virus-Fighting drug in healthy volunteers
NCT ID NCT06444048
Summary
This was a first-in-human study to check if a new drug called EV68-228-N is safe for people and to see how the body processes it. The study involved 36 healthy adult volunteers who received a single dose of the drug or a placebo. Researchers carefully monitored participants for side effects and measured drug levels in their blood over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENTEROVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Baltimore, Maryland, 21201-1509, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-0011, United States
Conditions
Explore the condition pages connected to this study.